Latest revenue
$5.0K
as of 2025-09-30
Latest net income
$-19.0M
as of 2025-09-30
Net margin
-380280.0%
as of 2025-09-30
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $564.0M
- Enterprise value
- $564.0M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $7.73
- 52-wk low
- $2.56
- Beta
- —
- Shares out
- 194.5M
5-year trend
About ALT
Business description and risk factors will appear here once ALT's latest filing is fully ingested.
Profitability
Operating margin
-230461.0%
55.3%Net margin
-214861.0%
54.8%Return on equity
-39.2%
49.1%Return on assets
-31.5%
53.9%Leverage
Debt / equity
0.24×
91.3%Long-term debt / equity
0.15×
516.7%Debt / assets
19.7%
73.4%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | — | — | $-22.6M | -15.3% | — |
Q4 2025 2025-12-31 | $26.0K | +420.0% | $-27.4M | -18.0% | -105223.1% |
Q3 2025 2025-09-30 | $5.0K | 0.0% | $-19.0M | +16.8% | -380280.0% |
Q2 2025 2025-06-30 | $5.0K | 0.0% | $-22.1M | +10.1% | -442920.0% |
Q1 2025 2025-03-31 | $5.0K | 0.0% | $-19.6M | +19.8% | -391500.0% |
Q4 2024 2024-12-31 | $5.0K | — | $-23.2M | — | -463600.0% |
Q3 2024 2024-09-30 | $5.0K | -98.6% | $-22.8M | -10.5% | -456900.0% |
Q2 2024 2024-06-30 | $5.0K | -16.7% | $-24.6M | -53.4% | -492800.0% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Pharmaceutical Preparations · SIC 2834
Your notes
Keep private notes on ALT — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$325.8K
Insider selling
$0
Net activity
+$325.8K
Distinct insiders
6
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ALT
Institutional value
$103.2M
Total shares held
33.8M
Distinct holders
92
-89 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 12.8M | $39.4M | +3.1M (+31.9%) | Added |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 5.7M | $17.4M | — | New |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.4M | $16.6M | — | New |
| 4 | Nuveen, LLC | 2.3M | $7.2M | +1.1M (+87.6%) | Added |
| 5 | DIMENSIONAL FUND ADVISORS LP | 1.0M | $3.2M | +762.2K (+268.7%) | Added |
| 6 | UBS Group AG | 904.8K | $2.8M | +262.7K (+40.9%) | Added |
| 7 | VANGUARD FIDUCIARY TRUST CO | 869.3K | $2.7M | — | New |
| 8 | BNP PARIBAS FINANCIAL MARKETS | 435.1K | $1.3M | +257.8K (+145.4%) | Added |
| 9 | Bank of New York Mellon Corp | 413.5K | $1.3M | +59.3K (+16.7%) | Added |
| 10 | Beirne Wealth Consulting Services, LLC | 411.9K | $1.3M | +35.4K (+9.4%) | Added |
| 11 | Steward Partners Investment Advisory, LLC | 251.8K | $775.5K | +6.4K (+2.6%) | Added |
| 12 | BROWN WEALTH MANAGEMENT, LLC | 236.1K | $727.3K | -22.5K (-8.7%) | Trimmed |
| 13 | Invesco Ltd. | 227.9K | $701.8K | +13.0K (+6.1%) | Added |
| 14 | COMMONWEALTH EQUITY SERVICES, LLC | 160.4K | $493.9K | -21.1K (-11.6%) | Trimmed |
| 15 | RHUMBLINE ADVISERS | 155.7K | $479.5K | +34.2K (+28.1%) | Added |
| 16 | HSBC HOLDINGS PLC | 154.4K | $476.2K | -110.1K (-41.6%) | Trimmed |
| 17 | STIFEL FINANCIAL CORP | 134.6K | $414.6K | +11.2K (+9.1%) | Added |
| 18 | WEALTH EFFECTS LLC | 131.9K | $406.4K | +20.2K (+18.1%) | Added |
| 19 | DEUTSCHE BANK AG\ | 124.5K | $383.5K | +44.6K (+55.8%) | Added |
| 20 | JPMORGAN CHASE & CO | 127.5K | $367.2K | +23.0K (+22.0%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once ALT's latest filing finishes processing.